The Effect of Dabigatran on Select Specialty Coagulation Assays

Dabigatran etexilate is a new oral anticoagulant that functions as a direct thrombin inhibitor. An inhibitor of thrombin has the potential to interfere with essentially all clot-based coagulation assays and select chromogenic assays, whereas the drug would not be expected to interfere in antigen-bas...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	American journal of clinical pathology Ročník 139; číslo 1; s. 102 - 109
Hlavní autoři:	Adcock, Dorothy M., Gosselin, Robert, Kitchen, Steve, Dwyre, Denis M.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England Oxford University Press 01.01.2013
Témata:	Activated Protein C Resistance - blood Administration, Oral Antithrombins - pharmacology Benzimidazoles - pharmacology Blood Coagulation - drug effects Blood Coagulation Tests Dabigatran Diagnostic Errors Factor VIII - analysis False Positive Reactions Humans In Vitro Techniques Partial Thromboplastin Time - methods Protein S Deficiency - blood Prothrombin - analysis Pyridines - pharmacology Thrombin - antagonists & inhibitors
ISSN:	0002-9173, 1943-7722, 1943-7722
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!